Yayınlar & Eserler

Yayın Ağı
Makaleler 17
Tümü (17)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (17)
ESCI (3)
Scopus (17)
TRDizin (4)

1. Prognostic value of PSMA PET–derived tumor volume in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide

Atasever T., Babacan G. B., Ekinci Ö. B., Buyukkuscu A., Uslu B. S., Kabaca F. Z. Y., et al.
Cancer Imaging , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Graves’ disease: is hyperthyroidism still present 6 months after radioactive iodine treatment really a failure?

Acar Tayyar M. N., Uyanik E., Mülazimoğlu M., ÖNER TAMAM M., KARYAĞAR S., Biçen Altin M. E., et al.
Nuclear Medicine Communications , cilt.46, sa.11, ss.1037-1042, 2025 (SCI-Expanded, Scopus)

3. Can Hemogram Parameters Be Used as a Biomarker for Thyroid Carcinomas?

Durmus A., KESİCİ U., Genc M. S., Mazlum A. F., Ercan L. D., Duman M. G., et al.
Annali Italiani di Chirurgia , cilt.96, sa.11, ss.1571-1577, 2025 (SCI-Expanded, Scopus) Creative Commons License

4. A comparison of image quality between digital and analog pet for spatial resolution: A phantom study

Karaca M., Doyuran M., ÇAKIR T., KARYAĞAR S., ÇAĞLAR M.
International Journal of Radiation Research , cilt.23, sa.2, ss.397-405, 2025 (SCI-Expanded, Scopus) Creative Commons License

5. How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA

Güven O., KARYAĞAR S., Arici S., ÖZÜLKER T., Can O.
Nuclear Medicine Communications , cilt.44, sa.9, ss.816-824, 2023 (SCI-Expanded, Scopus)

6. Unusual spread of the follicular thyroid carcinoma, metastases to liver and pancreas Propagation inhabituelle du carcinome folliculaire de la thyroïde, métastases au foie et au pancréas

Babacan G., KARYAĞAR S., Saraçoğlu S., Sağlampınar Karyağar S., Ekmekçioğlu Ö.
Medecine Nucleaire , cilt.47, sa.4, ss.208-210, 2023 (SCI-Expanded, Scopus)

7. Comparison of Radioactive Iodine Activities in Terms of Short-and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer Düşük Risk Grubundaki Diferansiye Tiroid Kanseri Hastalarında Ablasyon Tedavisinde Radyoaktif İyot Aktivitelerinin Kısa ve Uzun Dönem Sonuçları Açısından Karşılaştırılması

Saraçoğlu S., Güven O., Babacan G. B., KARYAĞAR S., ÖZÜLKER T., Ergür S., et al.
Molecular Imaging and Radionuclide Therapy , cilt.32, sa.2, ss.112-116, 2023 (ESCI, Scopus, TRDizin)

8. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy

Sakin A., Sahin S., Karyagar S. S., KARYAĞAR S., atci M., Akboru M. H., et al.
Journal of Gastrointestinal Cancer , cilt.53, sa.2, ss.341-347, 2022 (ESCI, Scopus)

9. Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?

KARYAĞAR S., Güven O., Karyaǧar S. S., Arici S., Selvi O., Geredeli Ç., et al.
Nuclear Medicine Communications , cilt.42, sa.9, ss.1011-1016, 2021 (SCI-Expanded, Scopus)

10. Correlations of the 68Ga-PSMA PET/CT derived primary prostate tumor PSMA expresstion parameters and metastatic patterns in patients with Gleason Score >7 prostate cancer

Karyagar S. S., KARYAĞAR S., Guven O.
Hellenic Journal of Nuclear Medicine , cilt.23, sa.2, ss.120-124, 2020 (SCI-Expanded, Scopus)

11. The predictive value of proportional evaluation based on the metabolic activity of cervical lymph nodes on pet/ct imaging in patients with larynx cancer Larinks Kanserli Hastalarda PET/BT Görüntülemede Servikal Lenf Nodlarının Metabolik Aktivitesine Dayanan Oransal Değerlendirmenin Prediktif Değeri

Karyağar S. S., KARYAĞAR S., Güven O., Üstün O., Atar Y., UYAR Y.
Molecular Imaging and Radionuclide Therapy , cilt.29, sa.2, ss.59-64, 2020 (ESCI, Scopus, TRDizin)

12. Ileal neuroendocrin tumor metastasis to breast diagnosed with Ga-68 DOTATATE PET/CT Ga-68 DOTATATE PET/BT ile tespit edilen ileal nöroendokrin tümör meme metastazı

Karyağar S. S., Güven O., KARYAĞAR S.
Molecular Imaging and Radionuclide Therapy , cilt.28, sa.3, ss.129-131, 2019 (Scopus, TRDizin)

13. Urine endothelin-1 levels as a predictor of renal scarring in children with urinary tract infections

Yilmaz A., GEDİKBAŞI A., ŞEVKETOĞLU E., KARYAĞAR S., HATİPOĞLU S. S., Kiyak A., et al.
Clinical Nephrology , cilt.77, sa.3, ss.219-224, 2012 (SCI-Expanded, Scopus)

14. Urine macrophage migration inhibitory factor levels in children with renal scarring due to recurrent urinary tract infections Tekrarlayan üriner sistem enfeksiyonlarina baǧli oluşan renal skarda i̇drar makrofaj migrasyon i̇nhibitör faktör düzeylerinin deǧerlendirilmesi

GEDİKBAŞI A., HATİPOĞLU S. S., Yilmaz A., ŞEVKETOĞLU E., KARYAĞAR S., Kiyak A., et al.
Medical Journal of Bakirkoy , cilt.7, sa.2, ss.52-55, 2011 (Scopus, TRDizin)

15. Urine neutrophil gelatinase associated lipocalin (uNGAL) as predictor of renal scarring

Yilmaz A., GEDİKBAŞI A., ŞEVKETOĞLU E., KARYAĞAR S., Kiyak A., Mulazimoglu M., et al.
Paediatria Croatica , cilt.54, sa.4, ss.173-176, 2010 (SCI-Expanded, Scopus)

16. Urinary macrophage migration inhibitory factor in children with urinary tract infection

ŞEVKETOĞLU E., Yilmaz A., GEDİKBAŞI A., KARYAĞAR S., Kiyak A., Mulazimoglu M., et al.
Pediatric Nephrology , cilt.25, sa.2, ss.299-304, 2010 (SCI-Expanded, Scopus)

17. Early prediction of urinary tract infection with urinary neutrophil gelatinase associated lipocalin

Yilmaz A., ŞEVKETOĞLU E., GEDİKBAŞI A., KARYAĞAR S., Kiyak A., Mulazimoglu M., et al.
Pediatric Nephrology , cilt.24, sa.12, ss.2387-2392, 2009 (SCI-Expanded, Scopus)
Metrikler

Yayın

17

Yayın (WoS)

17

Yayın (Scopus)

17

H-İndeks (WoS)

4

Atıf (Scopus)

176

H-İndeks (Scopus)

6

Tez Danışmanlığı

4

Açık Erişim

5